Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives

Aim. To evaluate the efficacy of the antiviral drug riamilovir (trade name – «Triazavirin®») for the prevention of SARS-CoV-2 infection (COVID-19) and other acute respiratory viral infections in young people from organized groups. Materials and methods. The study involved 386 individuals aged 18–...

Full description

Saved in:
Bibliographic Details
Main Authors: Konstantin V. Kozlov, Oleg V. Maltsev, Kristina V. Kasyanenko, Vitalii S. Sukachev, Andrei V. Saulevich, Sergey S. Karyakin, Alexey D. Dubrovin, Roman N. Smirnov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2024-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/637437/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!